Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
2.650
-0.070 (-2.57%)
At close: Jul 15, 2025, 4:00 PM
2.649
-0.001 (-0.03%)
After-hours: Jul 15, 2025, 5:14 PM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $562.18 million as of July 15, 2025. Its market cap has increased by 158.32% in one year.
Market Cap
562.18M
Enterprise Value
492.94M
1-Year Change
158.32%
Ranking
Category
Stock Price
$2.65
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $562.18M, a decrease of -75.44%. That is a compound annual growth rate of -29.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 577.03M | 158.55% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 715.76B |
| Johnson & Johnson | 376.89B |
| AbbVie | 337.95B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 272.14B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 230.48B |
| AstraZeneca | 218.74B |